B.1.1.7 became the dominant variant in Lebanon.

@inproceedings{Younes2021B117BT,
  title={B.1.1.7 became the dominant variant in Lebanon.},
  author={Mahmoud I. Younes and Kassem Hamze and Daniel P Carter and Karen L. Osman and Richard Vipond and Miles W. Carroll and Steven T. Pullan and Hassan Nassar and Nada Mohamad and Mohamad S. I. Makki and Maysaa Ghadar and Paul A Nguewa and Fadi Abdel Sater},
  booktitle={medRxiv},
  year={2021}
}
Recently, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) designated VOC 202012/01 (or B.1.1.7 lineage) has become highly prevalent in several countries, after first being described in the United Kingdom (UK). Its rate of transmission has been estimated to be increased compared to other lineages. In the present study, we show the emergence, dominance and the rapid spread of the B.1.1.7 lineage in Lebanon. 
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay
TLDR
The authors' multiplexed RT-qPCR test showed 97% clinical sensitivity and retesting 6,886 SARS-CoV-2 positive samples obtained during three campaigns performed within one month, revealed pervasive spread of B.1.1-1-7 with an average prevalence of 82%.
Comparative Diagnostic Accuracy of the STANDARD M10 Assay for the Molecular Diagnosis of SARS-CoV-2 in the Point-of-Care and Critical Care Settings
TLDR
The real-world performance of the novel RT-PCR STANDARD M10 SARS-CoV-2 assay in a large number of nasopharyngeal specimens eluted in universal transport medium was estimated and the diagnostic accuracy was 100% in testing both NP samples eluting in an inactivated transport medium and LRT specimens.
Classifying COVID-19 variants based on genetic sequences using deep learning models
TLDR
An alignment-free k-mer based LSTM (Long Short-Term Memory) deep learning model that can classify 20 different variants of COVID-19, which handles the class imbalance problem by sampling a fixed number of sequences for each class label, and handles the vanishing gradient problem in LSTMs arising from long sequences by dividing the sequence into fixed lengths.

References

SHOWING 1-9 OF 9 REFERENCES
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
TLDR
A rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread and is designed to provide a real-time bird’s-eye view of the diversity of the hundreds of thousands of genome sequences collected worldwide.
B.1.258$Δ$, a SARS-CoV-2 variant with $Δ$H69/$Δ$V70 in the Spike protein circulating in the Czech Republic and Slovakia
TLDR
SARS-CoV-2 mutants carrying the $Δ$H69/$Δ $V70 deletion in the amino terminal domain of the Spike protein emerged independently in at least six lineages of the virus, which shows that routine RT-qPCR tests are incapable of distinguishing among these lineages and often lead to the false conclusion that clinical samples contain the B.1.7 variant.
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
TLDR
These data reveal strong positive selection on SARS-CoV-2 during convalescent plasma therapy and identify the combination of Spike mutations D796H and deltaH69/deltaV70 as a broad antibody resistance mechanism against commonly occurring antibody responses to Sars-Cov-2.
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore
TLDR
An updated primer scheme with 22 additional primers to improve genome coverage and cost savings which bring the reagent cost down to £10 per sample making it practical for individual labs to sequence thousands of SARS-CoV-2 genomes to support national and international genomic epidemiology efforts.
A Rapid and Low-Cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-Based RT-qPCR
TLDR
This protocol could be used as a second test to confirm the diagnosis in patients who were already positive to COVID-19 but showed false negative results for S-gene, in case of shortage in sequencing.
Two-step strategy for the identification of SARS-CoV-2 variants co-occurring with spike deletion H69-V70
  • the COVID-Diagnosis HCL Study Group
Thermo Fisher's COVID-19 tests: designed with virus mutations in mind
    Two-step strategy for the identification of SARS-CoV-2 variants co-occurring with spike deletion H69-V70, Lyon, France, August to December 2020. the COVIDDiagnosis HCL Study Group
    • medRxiv
    • 2022
    Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom